Metaraminol

From Wikipedia, the free encyclopedia

Metaraminol
Systematic (IUPAC) name
3-[(1R,2S)-2-amino-1-hydroxy-propyl]phenol
Identifiers
CAS number 54-49-9
ATC code C01CA09
PubChem 5906
DrugBank APRD00555
Chemical data
Formula C9H13NO2 
Mol. mass 167.205 g/mol
Pharmacokinetic data
Bioavailability n/a
Protein binding ~45%
Metabolism Hepatic
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

C(AU) C(US)
Legal status

POM(UK)
Routes Intravenous

Metaraminol (INN, trade name Aramine) is a potent sympathomimetic amine used in the prevention and treatment of hypotension, particularly as a complication of anesthesia. It is an α1-adrenergic receptor agonist with some β effect.

Metaraminol is also used in the treatment of priapism. Although not approved for this use, it appears to be effective.[1][2][3]

[edit] References

  1. ^ McDonald M, Santucci R (2004). "Successful management of stuttering priapism using home self-injections of the alpha-agonist metaraminol.". Int Braz J Urol 30 (2): 121–2. doi:10.1590/S1677-55382004000200007. PMID 15703094. 
  2. ^ Koga S, Shiraishi K, Saito Y (1990). "Post-traumatic priapism treated with metaraminol bitartrate: case report.". J Trauma 30 (12): 1591–3. PMID 2258979. 
  3. ^ Block T, Sturm W, Ernst G, Staehler G, Schmiedt E (1988). "[Metaraminol in therapy of various forms of priapism]". Urologe A 27 (4): 225–9. PMID 3140463. 
Tablets  This pharmacology-related article is a stub. You can help Wikipedia by expanding it.
v • d • e
Cardiac stimulants excluding cardiac glycosides (C01C)
Adrenergic and dopaminergic agents
Phosphodiesterase inhibitors (PDE3I)
Other cardiac stimulants